Table 6 Characteristics of discordant subjects at risk of false positive LSM or false negative FibroTest
Characteristics | Discordant not reinvestigated | Discordant reinvestigated |
|---|---|---|
Number of subjects | 30 | 18 |
Age >60 years | 14/30 (47%) | 4/18 (22%) |
Male (%) | 21 (70%) | 12 (67%) |
Fatty liver risk factor (Alcohol or metabolic) | ||
Self-declared alcohol consumption at risk* | 8/30 (27%) | 2/18 (11%) |
Elevated Carbohydrate Deficient Transferin (>1.6%) | 9/30 (30%) | 12/18 (67%) (P = 0.01) |
Alcohol at risk (either consumption or CDT) | 16/30 (53%) | 13/18 (72%) |
BMI >= 27.0 | 10/30 (33%) | 4/18 (22%) |
Metabolic factor of ATP-III classification (at least one) | ||
Glucose >= 6.1 mmol/L or diabetes treatment | 7/30 (23%) | 2/18 (11%) |
Central obesity waist >102 male >88 female | 7/30 (23%) | 2/18 (11%) |
Triglycerides >= 1.7 mmol/L or fibrate treatment | 8/30 (27%) | 2/17 (12%) |
Hypertension or treatment | 12/30 (40%) | 2/18 (11%) (P = 0.05) |
HDL-cholesterol <1.03 mmol/L male <1.29 mmol/L female | 2/30 (7%) | 1/18 (6%) |
Steatosis predicted by SteatoTest | 7/30 (23%) | 3/17 (18%) |
HCV antibody positive | 0/30 (0%) | 0/18 (0%) |
HIV antibody positive | 0/30 (0%) | 0/18 (0%) |
HBsAg antigen positive | 1/30 (3%) | 0/18 (0%) |